- Zacks•16 hours ago
Bayer AG's (BAYRY) fourth-quarter 2016 core earnings increased 10.2% year over year to ???1.19 per share (approximately $1.28). Reported earnings missed the Zacks Consensus Estimate of $1.37.
Pfizer Inc. (PFE) announced that its Biologics License Application (BLA) for leukemia candidate inotuzumab ozogamicin has been accepted for priority review by the FDA.
- Zacks•6 days ago
Shire's (SHPG) fourth-quarter results were encouraging with the company beating both top- and bottom-line estimates.
SNSS : Summary for Sunesis Pharmaceuticals, Inc. - Yahoo Finance
Sunesis Pharmaceuticals, Inc. (SNSS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.13 x 2000|
|Day's Range||4.10 - 4.35|
|52 Week Range||2.64 - 6.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.43|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|